Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

307
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
307
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

338
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
338
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

268
Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
268
Equivalence: In Vitro and In Vivo Bioequivalence01:17

Equivalence: In Vitro and In Vivo Bioequivalence

295
Body:Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts.
295
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

197
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
197

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defibrillation: prevention, safety and literacy are key.

Resuscitation plus·2025
Same author

Job-exposure matrix (JEM) validity on crystalline silica among systemic sclerosis patients.

Occupational medicine (Oxford, England)·2025
Same author

Factors associated with early relapse of infantile haemangioma in children treated for at least six months with oral propranolol: A case-control study using the 2014-2021 French Ouest DataHub.

Annales de dermatologie et de venereologie·2023
Same author

Determination of Glyphosate and AMPA in Blood Can Predict the Severity of Acute Glyphosate Herbicide Poisoning.

Laboratory medicine·2022
Same author

Home-based exercise in autoimmune myasthenia gravis: A randomized controlled trial.

Neuromuscular disorders : NMD·2021
Same author

[Screening of occupational exposure to asbestos and silica by job-exposure matrix among patients with lung cancer and mesothelioma].

Revue des maladies respiratoires·2019

Related Experiment Video

Updated: Feb 26, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

[Non-inferiority and equivalence trials: Key methodological issues].

M Herr1, A Descatha2, P Aegerter3

  • 1Inserm, U1168, vieillissement et maladies chroniques : approches épidémiologique et de santé publique (VIMA), 94800 Villejuif, France; UMR-S 1168, université Versailles - Saint-Quentin-en-Yvelines, 78180 Montigny-le-Bretonneux, France; Département hospitalier d'épidémiologie et de santé publique, hôpitaux universitaires de Paris Île-de-France Ouest, AP-HP, site Ambroise-Paré, 92100 Boulogne-Billancourt, France; Département hospitalier d'épidémiologie et de santé publique, hôpitaux universitaires de Paris Île-de-France Ouest, AP-HP, site Sainte-Périne, 75016 Paris, France.

La Revue De Medecine Interne
|July 12, 2017
PubMed
Summary

Non-inferiority and equivalence trials evaluate new treatments that offer advantages beyond efficacy, like improved safety. Understanding their distinct methodology is crucial for interpreting trial results and advancing medical treatments.

Keywords:
Clinical trialsEquivalenceEssais cliniquesMethodologyMéthodologieNon-inferiorityNon-inférioritéÉquivalence

More Related Videos

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

9.3K
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.4K

Related Experiment Videos

Last Updated: Feb 26, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

9.3K
The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.4K

Area of Science:

  • Clinical Trials Methodology
  • Pharmaceutical Research
  • Medical Treatment Evaluation

Background:

  • New treatments may not be superior but offer other benefits (e.g., safety).
  • Non-inferiority and equivalence trials are designed for such scenarios.
  • These trial types differ methodologically from superiority trials.

Purpose of the Study:

  • To explain the methodology of non-inferiority and equivalence trials.
  • To highlight critical issues and decision points in these trial designs.
  • To inform readers about the nuances of these important clinical trial types.

Main Methods:

  • Presentation of general methodology: hypotheses, decision rules, sample size, and analysis.
  • Use of examples and graphic illustrations for clarity.
  • Identification and discussion of key issues, including comparator and non-inferiority margin selection.

Main Results:

  • The article provides a comprehensive overview of non-inferiority and equivalence trial design.
  • It elucidates the statistical and practical considerations for conducting and interpreting these trials.
  • Key challenges, such as selecting appropriate comparators and defining non-inferiority margins, are addressed.

Conclusions:

  • A clear understanding of non-inferiority and equivalence trial methodology is essential.
  • Careful consideration of the comparator and non-inferiority margin is critical for trial validity.
  • These trials play a vital role in introducing new treatments with added benefits.